BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28252445)

  • 1. Comparing the dosimetric impact of interfractional anatomical changes in photon, proton and carbon ion radiotherapy for pancreatic cancer patients.
    Houweling AC; Crama K; Visser J; Fukata K; Rasch CR; Ohno T; Bel A; van der Horst A
    Phys Med Biol; 2017 Apr; 62(8):3051-3064. PubMed ID: 28252445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric effects of anatomical changes during fractionated photon radiation therapy in pancreatic cancer patients.
    van der Horst A; Houweling AC; van Tienhoven G; Visser J; Bel A
    J Appl Clin Med Phys; 2017 Nov; 18(6):142-151. PubMed ID: 28980445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of interfractional anatomical changes on the accumulated dose in carbon ion therapy of pancreatic cancer patients.
    Houweling AC; Fukata K; Kubota Y; Shimada H; Rasch CR; Ohno T; Bel A; van der Horst A
    Radiother Oncol; 2016 May; 119(2):319-25. PubMed ID: 26993417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the benefit of PBS vs. VMAT dose distributions in terms of dosimetric sparing and robustness against inter-fraction anatomical changes for pediatric abdominal tumors.
    Guerreiro F; Zachiu C; Seravalli E; Ribeiro CO; Janssens GO; Ries M; de Senneville BD; Maduro JH; Brouwer CL; Korevaar EW; Knopf AC; Raaymakers BW
    Radiother Oncol; 2019 Sep; 138():158-165. PubMed ID: 31302390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy.
    Yamada M; Sato H; Ieko Y; Miyasaka Y; Kanai T; Yano N; Ono T; Akamatsu H; Harada M; Ichikawa M; Teranishi Y; Kikuchi Y; Nemoto K
    Radiat Oncol; 2019 Nov; 14(1):207. PubMed ID: 31752932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
    Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
    Chi A; Lin LC; Wen S; Yan H; Hsi WC
    Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
    Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
    Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of interfractional anatomical variation and setup correction methods on interfractional dose variation in IMPT and VMAT plans for pancreatic cancer patients: A planning study.
    Ashida R; Nakamura M; Yoshimura M; Mizowaki T
    J Appl Clin Med Phys; 2020 Jul; 21(7):49-59. PubMed ID: 32350969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
    Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
    Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
    Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
    Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer.
    Steitz J; Naumann P; Ulrich S; Haefner MF; Sterzing F; Oelfke U; Bangert M
    Radiat Oncol; 2016 Oct; 11(1):134. PubMed ID: 27717378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
    Botas P; Grassberger C; Sharp G; Paganetti H
    Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignancies.
    Yang Z; Chang Y; Brock KK; Cazoulat G; Koay EJ; Koong AC; Herman JM; Park PC; Poenisch F; Li Q; Yang K; Wu G; Anderson B; Ohrt AN; Li Y; Zhu XR; Zhang X; Li H
    Radiother Oncol; 2019 May; 134():101-109. PubMed ID: 31005203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.
    Müller BS; Duma MN; Kampfer S; Nill S; Oelfke U; Geinitz H; Wilkens JJ
    Phys Med; 2015 May; 31(3):266-72. PubMed ID: 25724350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO
    Troost EGC; Wink KCJ; Roelofs E; Simone CB; Makocki S; Löck S; van Kollenburg P; Dechambre D; Minken AWH; van der Stoep J; Avery S; Jansen N; Solberg T; Bussink J; de Ruysscher D
    Br J Radiol; 2020 Mar; 93(1107):20190879. PubMed ID: 31804145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose hypofractionated pencil beam scanning carbon ion radiotherapy for lung tumors: Dosimetric impact of different spot sizes and robustness to interfractional uncertainties.
    Mastella E; Mirandola A; Russo S; Vai A; Magro G; Molinelli S; Barcellini A; Vitolo V; Orlandi E; Ciocca M
    Phys Med; 2021 May; 85():79-86. PubMed ID: 33984821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.
    Thompson RF; Mayekar SU; Zhai H; Both S; Apisarnthanarax S; Metz JM; Plastaras JP; Ben-Josef E
    Med Phys; 2014 Aug; 41(8):081711. PubMed ID: 25086521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
    Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
    Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.